Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proteome Factory is a Berlin-based private proteomics and protein analytics company that provides contract research, fee-for-service analysis, and selected products for biotechnology, biopharmaceutical, and academic customers. The company was founded in 2000 as a spin-off from Technische Universität Berlin and Charité and focuses on proteomics, biomarker and target discovery and validation, protein identification and characterization, antibody sequencing, and mass spectrometry-based analytical services. Its offering spans differential proteomics, targeted protein quantification, glycoprofiling, biosimilar and host-cell protein analysis, de novo peptide and antibody sequencing, and protein quality control. Proteome Factory also markets tools and kits such as MeCAT kits and spotXpress, supporting quantitative proteomics workflows. The business appears to be service-led rather than a therapeutic drug developer, with commercial operations centered on analytical capabilities and platform technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proteome Factory.